Kidswell Bio Corporation Logo

Kidswell Bio Corporation

Biopharmaceutical firm focused on R&D of therapeutics for pediatric healthcare.

4584 | T

Overview

Corporate Details

ISIN(s):
JP3386460004
LEI:
Country:
Japan
Address:
中央区新川一丁目2番12号

Description

Kidswell Bio Corporation is a biopharmaceutical company engaged in the research and development of innovative therapeutics, with a particular focus on pediatric healthcare. The company's operations are centered on three main pillars: the Biosimilars business, which leverages expertise in cell line development and CMC; the Cell Therapy business, which pursues regenerative medicine through its subsidiary S-Quatre Corporation for conditions such as cerebral palsy; and the New Biologics business, focused on developing novel drugs. The company aims to create a comprehensive healthcare system for children and their families through its advanced R&D pipeline.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-11-11 07:23
確認書
Japanese 8.1 KB
2022-11-11 07:17
四半期報告書-第23期第2四半期(令和4年7月1日-令和4年9月30日)
Japanese 233.9 KB
2022-08-12 08:04
確認書
Japanese 8.1 KB
2022-08-12 08:04
四半期報告書-第23期第1四半期(令和4年4月1日-令和4年6月30日)
Japanese 145.2 KB
2022-06-28 08:03
確認書
Japanese 8.5 KB
2022-06-28 08:03
内部統制報告書-第22期(令和3年4月1日-令和4年3月31日)
Japanese 22.6 KB
2022-06-28 08:02
有価証券報告書-第22期(令和3年4月1日-令和4年3月31日)
Japanese 1.3 MB
2022-02-14 07:26
四半期報告書-第22期第3四半期(令和3年10月1日-令和3年12月31日)
Japanese 147.9 KB
2021-11-10 07:39
四半期報告書-第22期第2四半期(令和3年7月1日-令和3年9月30日)
Japanese 186.0 KB
2021-08-13 08:07
四半期報告書-第22期第1四半期(令和3年4月1日-令和3年6月30日)
Japanese 143.8 KB
2021-06-30 04:37
確認書
Japanese 8.1 KB
2021-06-30 04:35
内部統制報告書-第21期(令和2年4月1日-令和3年3月31日)
Japanese 21.9 KB
2021-06-30 04:34
有価証券報告書-第21期(令和2年4月1日-令和3年3月31日)
Japanese 1.3 MB
2021-02-10 07:11
四半期報告書-第21期第3四半期(令和2年10月1日-令和2年12月31日)
Japanese 150.7 KB
2020-11-11 08:27
四半期報告書-第21期第2四半期(令和2年7月1日-令和2年9月30日)
Japanese 187.1 KB

Automate Your Workflow. Get a real-time feed of all Kidswell Bio Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kidswell Bio Corporation

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kidswell Bio Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.